1. EachPod

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives - Podcast

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at HCPLive.com/Clinical/Endocrinology.

Please direct podcast-related inquiries to [email protected].



Editor's note: Episodes predating January 2023 were hosted by Endocrinology Network. Episodes predating March 2022 were titled The Endocrine Outlook.

Health & Fitness Technology Tech News Science Medicine
Update frequency
every 5 days
Average duration
21 minutes
Episodes
160
Years Active
2020 - 2025
Share to:
Semaglutide & Tirzepatide Updates at ESC Congress 2025

Semaglutide & Tirzepatide Updates at ESC Congress 2025

At ESC 2025, a pair of presentations highlighted the ongoing debate over cardiovascular risk reduction with semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound), yielding conflicting sign…
00:13:33  |   Fri 05 Sep 2025
FDA Approves Semaglutide (Wegovy) for MASH

FDA Approves Semaglutide (Wegovy) for MASH

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!
In this episode, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Tra…
00:13:17  |   Fri 22 Aug 2025
ADCES 2025 Part 3 & Diabetes Tech Updates

ADCES 2025 Part 3 & Diabetes Tech Updates

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!

In this episode, Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training i…
00:13:44  |   Fri 22 Aug 2025
ADCES 2025 Recap Part 2

ADCES 2025 Recap Part 2

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!
In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Train…
00:21:29  |   Fri 22 Aug 2025
Orforglipron Topline Results & ADCES 2025 Part 1

Orforglipron Topline Results & ADCES 2025 Part 1

In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, share key insights and takeaways from the Association …
00:21:39  |   Tue 19 Aug 2025
Tirzepatide and SURPASS-CVOT Topline Results

Tirzepatide and SURPASS-CVOT Topline Results

On July 31, 2025, Eli Lilly and Company announced topline data from the SURPASS‑CVOT trial comparing tirzepatide (Mounjaro) to dulaglutide (Trulicity) in adults with type 2 diabetes and established a…
00:11:13  |   Tue 05 Aug 2025
Guideline Updates for Diabetes & Pregnancy

Guideline Updates for Diabetes & Pregnancy

Welcome back to Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives!

In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the ne…
00:30:17  |   Wed 23 Jul 2025
GLP-1s, SGLT2s, and Diabetes Barbie at ENDO 2025

GLP-1s, SGLT2s, and Diabetes Barbie at ENDO 2025

Welcome back to Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives!

In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, direct…
00:16:14  |   Mon 21 Jul 2025
Upcoming Research on Type 1 Diabetes in Pregnancy with Carol Levy, MD

Upcoming Research on Type 1 Diabetes in Pregnancy with Carol Levy, MD

In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders…
00:21:40  |   Fri 18 Jul 2025
BELIEVE, GLP-1/GIP Agonists, and CATALYST Results at ADA 2025

BELIEVE, GLP-1/GIP Agonists, and CATALYST Results at ADA 2025

In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders…
00:28:54  |   Wed 16 Jul 2025
American Diabetes Association 2025 Trial Recap - Part 1

American Diabetes Association 2025 Trial Recap - Part 1

In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders…
00:20:26  |   Wed 16 Jul 2025
American Diabetes Association 2025 Trial Recap - Part 1

American Diabetes Association 2025 Trial Recap - Part 1

In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders…
00:55:39  |   Tue 15 Jul 2025
The Diabetes Collective, with Rachael Sood, RN, MSN, APRN

The Diabetes Collective, with Rachael Sood, RN, MSN, APRN

In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, recorded during the 85th Scientific Sessions of the American Diabetes Association (ADA 2025) in Chicago, hos…
00:19:34  |   Tue 24 Jun 2025
Addressing America's Shortage of Diabetes Care Providers, with Jay Shubrook, DO, & Conan Tu, MD

Addressing America's Shortage of Diabetes Care Providers, with Jay Shubrook, DO, & Conan Tu, MD

In this episode of Diabetes Dialogue, recorded live at the 85th Scientific Sessions of the American Diabetes Association (ADA 2025), hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, welcome Jay …
00:19:24  |   Tue 24 Jun 2025
CATALYST Trial, Mifepristone, and Hypercortisolism in T2D, with John Buse, MD, PhD

CATALYST Trial, Mifepristone, and Hypercortisolism in T2D, with John Buse, MD, PhD

In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, speak with John Buse, MD, PhD, of the University of No…
00:27:59  |   Mon 23 Jun 2025
Updates from Dexcom at ADA 2025, with Kevin Sayer

Updates from Dexcom at ADA 2025, with Kevin Sayer

In this special episode recorded at 85th Scientific Sessions of the American Diabetes Association (ADA 2025), hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and T…
00:24:36  |   Sun 22 Jun 2025
REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD

REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD

In this special episode recorded at 85th Scientific Sessions of the American Diabetes Association (ADA 2025), hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and T…
00:19:29  |   Sun 22 Jun 2025
ADA 2025 Preview

ADA 2025 Preview

With a number of late-breaking presentations and high-profile phase 2 and 3 trials, the 2025 American Diabetes Association (ADA) Scientific Sessions reflect how rapidly the treatment landscape for ob…
00:15:54  |   Wed 11 Jun 2025
American Diabetes Association Consensus Report on MASLD

American Diabetes Association Consensus Report on MASLD

In this episode of Diabetes Dialogue, cohostsDiana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders …
00:14:55  |   Wed 04 Jun 2025
May 2025 Diabetes Tech & Breakthrough T1D Updates

May 2025 Diabetes Tech & Breakthrough T1D Updates

In this episode of Diabetes Dialogue, co-hosts hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Di…
00:17:21  |   Mon 02 Jun 2025
Disclaimer: The podcast and artwork embedded on this page are the property of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives. This content is not affiliated with or endorsed by eachpod.com.